Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Brunello

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 29, 2016
Isolated limb perfusion for the management limb threatening soft tissue sarcomas: The role of histological type on clinical outcomesM Rastrelli, S Mocellin, R Stramare, et al.
ESMO Open|August 5, 2021
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world studyM Nannini, A Rizzo, M C Nigro, et al.
ESMO Open|August 9, 2024
TRAbectedin in adVanced rEtroperitoneal well differentiated/dedifferentiated Liposarcoma and Leiomyosarcoma (TRAVELL): results of a phase II study from the Italian Sarcoma GroupC Fabbroni, G Grignani, B Vincenzi, et al.
ESMO Open|June 12, 2025
Sexual health in cancer care: a narrative review and position statement from the Italian Association of Medical Oncology (AIOM)A Rossi, A G Leone, M Lambertini, et al.
ESMO Open|February 6, 2026
Activity of chemotherapy in mesenchymal chondrosarcoma: a multicentre retrospective analysis within the Italian Sarcoma Group networkG G Baldi, A M Frezza, C Biagioni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2025
Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase II study from the Italian Sarcoma GroupL D'Ambrosio, A Merlini, A Brunello, et al.
Breast Cancer Research and Treatment|February 12, 2022
Systemic treatment in advanced phyllodes tumor of the breast: a multi-institutional European retrospective case-series analysesE Palassini, O Mir, G Grignani, et al.
Cell|February 19, 2021
Antidepressant drugs act by directly binding to TRKB neurotrophin receptorsPlinio C Casarotto, Mykhailo Girych, Senem M Fred, et al.
ESMO Open|March 8, 2025
Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trialA Vanzulli, R Vigorito, C Buonomenna, et al.
Nature Neuroscience|June 6, 2023
Psychedelics promote plasticity by directly binding to BDNF receptor TrkBRafael Moliner, Mykhailo Girych, Cecilia A Brunello, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 29, 2016
Isolated limb perfusion for the management limb threatening soft tissue sarcomas: The role of histological type on clinical outcomesM Rastrelli, S Mocellin, R Stramare, et al.
ESMO Open|August 5, 2021
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world studyM Nannini, A Rizzo, M C Nigro, et al.
ESMO Open|August 9, 2024
TRAbectedin in adVanced rEtroperitoneal well differentiated/dedifferentiated Liposarcoma and Leiomyosarcoma (TRAVELL): results of a phase II study from the Italian Sarcoma GroupC Fabbroni, G Grignani, B Vincenzi, et al.
ESMO Open|June 12, 2025
Sexual health in cancer care: a narrative review and position statement from the Italian Association of Medical Oncology (AIOM)A Rossi, A G Leone, M Lambertini, et al.
ESMO Open|February 6, 2026
Activity of chemotherapy in mesenchymal chondrosarcoma: a multicentre retrospective analysis within the Italian Sarcoma Group networkG G Baldi, A M Frezza, C Biagioni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2025
Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase II study from the Italian Sarcoma GroupL D'Ambrosio, A Merlini, A Brunello, et al.
Breast Cancer Research and Treatment|February 12, 2022
Systemic treatment in advanced phyllodes tumor of the breast: a multi-institutional European retrospective case-series analysesE Palassini, O Mir, G Grignani, et al.
Cell|February 19, 2021
Antidepressant drugs act by directly binding to TRKB neurotrophin receptorsPlinio C Casarotto, Mykhailo Girych, Senem M Fred, et al.
ESMO Open|March 8, 2025
Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trialA Vanzulli, R Vigorito, C Buonomenna, et al.
Nature Neuroscience|June 6, 2023
Psychedelics promote plasticity by directly binding to BDNF receptor TrkBRafael Moliner, Mykhailo Girych, Cecilia A Brunello, et al.
Pageof 5